Ben Friesem CTO & Co-Founder
Ben joined VeinWay as co-founder to lead our R&D program. With 10 years of experience in medical device research and development, Ben brings to this position a significant track record in medical device innovation. His experience ranges from developing implants for minimally invasive spinal orthopedics (Nuvasive), basic academic research, to intravascular implant development in the field of structural heart. In his previous role as Senior Development Engineer at Restore Medical (first employee), Ben played a major role designing and developing the Contraband System, a nitinol based cardiovascular implant and subsequent transcatheter delivery system to treat CHF. He has taken products from the concept generation stage to clinical trials. He is listed on six issued and pending patents. He is a broadly experienced engineer skilled in nitinol and catheter design and has extensive knowledge of the start-up ecosystem. Ben holds a B.Sc. in Biomedical Engineering from the California Polytechnic State University (Cal Poly), a M.Sc. in Biotechnology Engineering from Ben Gurion University, and an MBA in Healthcare Innovation from Reichman University.